CTRI/2020/07/026880尚未招募未知
Role Of Very Low Dose Of Factor VIII Prophylaxis In Severe Hemophilia A Patients
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with age greater than 13 years diagnosed as Severe Hemophilia A.
排除标准
- •Patients with other bleeding disorders like Von Willebrands Disease Patients with any liver disease or kidney disease
- •Patients on anticoagulation therapy
研究者
相似试验
已完成
不适用
Preventive Therapy In Hemophilia B using very low dose Factor IX.CTRI/2020/06/025789Maulana Azad Medical College20
进行中（未招募）
不适用
To compare the effectiveness of standard weight based dosing of Factor VIII prophylaxis against regimens using an individual's own rate of Factor VIII clearance in adult patients with severe Factor VIII deficiency (Haemophilia A).Severe Haemophilia AMedDRA version: 14.1Level: LLTClassification code 10018937Term: Haemophilia ASystem Organ Class: 100000004850EUCTR2013-003240-23-IESt. James' Hospital
已完成
不适用
Influence of factor VIII concentrate infusion on platelet activation, inflammatory parameters and endothelial parameters; a pilot studybleeding disorder1006447710003216HemophiliaNL-OMON33269niversitair Medisch Centrum Utrecht10
已完成
不适用
Clinical validation of Factor VIII allo-antibody assays in patients with hemophilia A. The correlation of factor VIII antibodies, measured with different assays, on factor VIII survival in patients with severe haemophilia A.Haemophilia A1006447710005330NL-OMON31749niversitair Medisch Centrum Sint Radboud50
已完成
1 期
FEIBA and Use of Blood Products in Cardiac SurgeryCardiovascular DiseaseNCT02577614Oregon Health and Science University12